Precision Biosciences (DTIL) Revenue Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 54.05% |
| 10 | Precision Biosciences | 181.80 Mn | 153.51 Mn | - | 7.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.27% |
| Dec 31, 2025 | 47.78% |
| Sep 30, 2025 | -87.91% |
| Jun 30, 2025 | -83.24% |
| Mar 31, 2025 | -79.40% |
| Dec 31, 2024 | -53.48% |
| Sep 30, 2024 | -71.17% |
| Jun 30, 2024 | -10.16% |
| Mar 31, 2024 | 2.46% |
| Dec 31, 2023 | -7.34% |
| Sep 30, 2023 | 21.23% |
| Jun 30, 2023 | 163.80% |
| Mar 31, 2023 | 7.85% |
| Dec 31, 2022 | 17.57% |
| Sep 30, 2022 | 14.81% |
| Jun 30, 2022 | -10.84% |
| Mar 31, 2022 | -15.32% |
| Dec 31, 2021 | 8.67% |
| Sep 30, 2021 | 111.49% |
| Jun 30, 2021 | 232.37% |